June 2026
The global circulating tumor DNA (ctDNA) market size is estimated to hit around USD 30.94 billion by 2035 increasing from USD 7.96 billion in 2025, with a CAGR of 14.54%.
June 2026
The global circulating tumor cells market size was evaluated at USD 14.68 billion in 2025 and is predicted to hit around USD 54.76 billion by 2035, growing at a CAGR of 14.07%.
September 2026
The global DNA nanotechnology market size was exhibited at USD 8.60 billion in 2026 and is predicted to surpass around USD 60.27 billion by 2035, with a solid CAGR of 24.24%.
September 2026
The plasmid DNA manufacturing market size was estimated at USD 3.20 billion in 2026 and is expected to hit around USD 12.45 billion by 2035, growing at a CAGR of 16.78%.
September 2026
The global DNA microarray market size was valued at USD 2.49 billion in 2024 and is expected to hit around USD 6.13 billion by 2034, at a CAGR of 9.43%.
September 2026
The global DNA sequencing market size reached USD 16.89 billion in 2026 and is projected to reach around USD 57.39 billion by 2035 with a soild CAGR of 14.59%.
September 2026
The U.S. DNA nanotechnology market size is accounted to hit around USD 18.03 billion by 2035 increasing from USD 2.52 billion in 2026, with a CAGR of 24.53%.
September 2026
The U.S. targeted DNA RNA sequencing market size is accounted to hit around USD 27.72 billion by 2035 increasing from USD 5.73 billion in 2026, with a CAGR of 19.17%.
September 2026
The DNA-based non-viral technologies market was valued at USD 6.57 billion in 2026, with leading companies including Thermo Fisher Scientific Inc., Lonza Group AG, Bio-Rad Laboratories, Inc., Promega Corporation, Qiagen N.V.
September 2026
The US viral vectors and plasmid DNA manufacturing market size is valued at USD 3.30 billion in 2026 and is predicted to hit USD 11.69 billion by 2035, with a CAGR of 15.20%.
September 2026
The U.S. DNA synthesis market generated USD 2.30 billion in 2026, with prominent U.S. DNA synthesis market companies including LGC Biosearch Technologie, Bioneer Corporation, Thermo Fisher Scientific, Inc.
September 2026
The viral vectors and plasmid DNA manufacturing market size is expected to hit USD 29.82 billion by 2035 from USD 8.42 billion in 2026 with a CAGR of 15.17%.
July 2026
The global recombinant DNA technology market size was valued at USD 913.36 billion in 2025 and is expected to hit around USD 1,719.89 billion by 2035, at a CAGR of 6.53%.
July 2026
The global DNA synthesis market size has been calculated at USD 5.93 billion in 2025 and is projected to reach around USD 34.39 billion by 2035, with a CAGR of 19.22%.
July 2026
The pan-tumor oncology treatment market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
June 2026
The global circulating biomarkers market size is estimated to hit around USD 15.62 billion by 2035 increasing from USD 5.17 billion in 2025, with a CAGR of 11.69%.
June 2026
The global DNA data storage market size is anticipated at USD 150.63 million in 2025 and is predicted to hit around USD 58,450.83 million by 2035, growing at a CAGR of 88.01%.
June 2026
The global pet DNA testing market size was valued at USD 447.94 million in 2025 and is expected to hit around USD 1,177.22 million by 2035, growing at a CAGR of 10.14% from 2026 to 2035.
June 2026
The solid tumor cancer treatment market size was valued at USD 5.64 billion in 2025 and is projected to hit around USD 9.14 billion by 2035 with a CAGR of 4.95%.
June 2026
The global neuroendocrine tumor treatment market size is estimated to surpass around USD 5.16 billion by 2035 from USD 2.88 billion in 2025, at a solid CAGR of 6.00%.
June 2026
The global targeted DNA RNA sequencing market size is estimated to hit around USD 80.78 billion by 2035, increasing from USD 14.28 billion in 2025, with a CAGR of 18.92%.
June 2026
The global DNA repair drugs market size reached USD 9.36 billion in 2025 and is predicted to surpass around USD 33.11 billion by 2035 with a notable CAGR of 13.47%.
May 2026
The U.S. plasmid DNA manufacturing market size was exhibited at USD 810 million in 2025 and is projected to hit USD 4,003 million by 2035, at a CAGR of 18.41%.
April 2026
The global tumor ablation market size is exhibited at USD 2.18 billion in 2025 and is predicted to be worth around USD 7.47 billion by 2035, with a CAGR of 13.11%.
January 2026
The global DNA polymerase market size is valued at USD 138.46 million in 2025 and is expected to hit around USD 159.08 million by 2035, growing at a CAGR of 1.40%.
January 2026
The global DNA ligases market size was valued at USD 382.16 million in 2025 and is predicted to hit around USD 806.15 million by 2035, growing at a CAGR of 7.75%.
December 2025
The global DNA diagnostics market size is accounted at USD 11.64 billion in 2025 and is projected to hit around USD 17.78 billion by 2035 with a CAGR of 4.32%.
December 2025
The global DNA synthesizer market size accounted for USD 412.55 million in 2025 and is expected to hit around USD 1,570.47 million by 2035 with a CAGR of 14.3%.
July 2025
The global DNA forensics market size was valued at USD 2.79 billion in 2024 and is projected to attain around USD 5.87 billion by 2034, with a CAGR of 7.18%.
July 2025
The global tumor necrosis factor inhibitor drugs market size is projected to hit around USD 51.55 billion by 2034 from USD 42.86 billion in 2024 with a CAGR of 1.86%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com